Floatz logo

HYDROMORPHONE HYDROCHLORIDE CII

Transarterial Chemoembolization

First Affiliated Hospital, Sun Yat-Sen UniversitySmall moleculePhase 4 / ApprovedActive
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Transarterial Chemoembolization cohort.

Asset / SponsorPhaseRating
Theprubicin
Xinrui Zhu，MD
Phase 3BB
SUFENTANYL
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
Amitriptyline
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
Ethiodized Oil
Xinrui Zhu，MD
Phase 3BB
S-Ketamine
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB

View all 13 →

Same molecule, other indications

HYDROMORPHONE HYDROCHLORIDE CII is also rated in:

Multimodal AnalgesiaDormant
BB
Indicative ·
69 / 100
View asset →
Real-world StudyDormant
BB
Indicative ·
69 / 100
View asset →
Enhanced Recovery After SurgeryDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →